About Us:

E-mail this page   Printable View

Leadership and Staff of the Sabin Vaccine Institute

Peter Hotez, M.D., Ph.D., F.A.A.P. - President, Sabin Vaccine Institute; Professor and Chair, Department of Microbiology, Immunology & Tropical Medicine, GWU

Peter Hotez is a medical and molecular parasitologist and a pediatrician, with a specialty interest in developing vaccines for tropical infectious diseases. Dr. Hotez obtained his B.A. (1980) in molecular biophysics and biochemistry from Yale University, and his M.D. (1987) and Ph.D. (1986) from the joint medical scientist training program of Weil Cornell University Medical College and the Rockefeller University. His doctoral dissertation was on the molecular parasitology of hookworm. Following pediatric residency training at the Massachusetts General Hospital (1987-88), Dr. Hotez was a Pfizer Postdoctoral Fellow in infectious diseases at Yale (1989-90), and was subsequently appointed to the faculty with a joint appointment in Pediatrics and Epidemiology & Public Health. In 2000, he relocated to the GWU School of Medicine. In addition to his responsibilities as Sabin President, Dr. Hotez also serves as the Walter G. Ross Professor and Chair of the Department of Microbiology, Immunology, and Tropical Medicine at The George Washington University School of Medicine, and Principal Scientist and Founding Director of the Human Hookworm Vaccine Initiative (HHVI). Dr. Hotez has written approximately 220 papers, op-ed pieces, and book chapters, including articles in the New England Journal of Medicine, Lancet, Science, PLoS Medicine, and all of the major parasitology and tropical medicine journals, as well as the Washington Post and Foreign Policy. He is a co-author of Parasitic Diseases, 5th Edition, and a co-editor of Krugman's Infectious Diseases of Children, 11th Edition, and is the founding Editor-in-Chief of PLoS Neglected Tropical Diseases. Dr. Hotez is the recipient of awards from the American Society of Tropical Medicine and Hygiene (Bailey K. Ashford Medal), the American Society of Parasitologists (Henry Baldwin Ward Medal), the Liverpool School of Tropical Medicine (Leverhulme Medal), the Pediatric Infectious Diseases Society (Young Investigator Award). He serves on the Scientific Advisory Board of the March of Dimes, and in 2006 was designated as an Ambassador of the Paul G. Rogers Society for Global Health Research for Research!America. Dr. Hotez holds a license to practice medicine in the District of Columbia. He was board certified in pediatrics in 1998and recertified in 2005.

Ciro de Quadros, M.D,, M.P.H., Executive Vice President, Sabin Vaccine Institute; Adjunct Professor, GWU

Before joining the Sabin Vaccine Institute in 2003, Dr. de Quadros was Director of the Division of Vaccines and Immunization of the Pan American Health Organization. He has also worked for the World Health Organization as Chief Epidemiologist for the Smallpox Eradication Program in Ethiopia. He participated in the pioneering development of surveillance and containment strategies for smallpox eradication and directed successful polio and measles eradication efforts for the Western Hemisphere. Dr. de Quadros is an Associate Adjunct Professor at the Johns Hopkins School of Hygiene and Public Health and an Adjunct Professor in the Department of Tropical Medicine at The George Washington University School of Medicine and Health Sciences. He completed his medical and public health studies in Brazil. 

 

Brian R. Davis, C.P.A. - Chief Financial Officer, Sabin Vaccine Institute
Mr. Davis has worked with the Sabin Vaccine Institute since 2005 and has recently been appointed their Chief Financial Officer.  Prior to joining Sabin, Mr. Davis owned an established accounting practice in Washington, DC that served the non-profit sector in areas of life science, education, economic development, and low-income housing.  Mr. Davis holds CPA certificates in Maryland and the District of Columbia as well as a B.A in Business Administration with a major in Finance from Michigan State University.  Mr. Davis is an active member of the American Institute of CPAs.

 

Ami Shah Brown, Ph.D., M.P.H. - Program Officer; Assistant Professor, GWU

Ami Shah Brown received her PhD in International Health from The Johns Hopkins Bloomberg School of Public Health. She has a Master of Public Health (MPH) degree from The Rollins School of Public Health of Emory University with a focus in Behavioral Sciences and Health Education and BA in Biology from the University of Pennsylvania. Before joining the Sabin Vaccine Institute, she worked as a Senior Research Program Coordinator in the Center for Immunization Research at the Johns Hopkins Bloomberg School of Public Health where she served as a primary member of the Clinical Vaccine Trials Consultants and primary instructor for an online academic course entitled, "Clinical Trials and Good Clinical Practice (GCP)." In this capacity, she has trained clinical trial professionals worldwide. Other experience includes laboratory and community work on various HIV vaccine trials, a fellowship with the Centers for Disease Control and Prevention's (CDC) National Centers for HIV, STD, and TB prevention (NCHSTP) to develop measures for behavioral surveillance, and with the Emory Vaccines Center, where she designed the community education and recruitment plan for HIV vaccine trials. Dr. Brown has extensive international field experience in sub-Saharan Africa, Asia, and Latin America.

David Diemert, M.D., F.R.C.P. (C) - Chief Medical Officer, Sabin Vaccine Institute; Assistant Professor, GWU

Dr. David Diemert is chief medical officer of the Human Hookworm Vaccine Initiative and an assistant professor at The George Washington University School of Medicine. In this capacity since 2005, Dr. Diemert's work at HHVI involves providing direct oversight for hookworm vaccine trials sponsored by the HHVI, both in the United States and in Brazil. His work in Brazil has involved preparing a trial site in partnership with the Fundação Oswaldo Cruz, which has included establishing a clinic in a rural area of Brazil, assembling and training a Brazilian clinical trials team, establishing quality laboratory facilities at the field site, and conducting preparatory studies of helminth epidemiology and immunology. Prior to joining the HHVI, Dr. Diemert worked for four years at the Malaria Vaccine Development Branch of the National Institute of Allergy and Infectious Diseases, where he was responsible for conducting clinical trials of novel malaria vaccines, both in the United States and in Mali, West Africa. Dr. Diemert earned his medical degree from the University of Alberta in Edmonton, Canada, and completed residency training at McGill University in Montréal. He is a Fellow of the Royal College of Physicians (Canada) with certification in the specialties of internal medicine, infectious diseases and medical microbiology. Additionally, he received training in clinical tropical medicine through the University of Alabama at Birmingham's Gorgas Course in Lima, Peru, as well as in clinical vaccine trials through the Johns Hopkins' Bloomberg School of Public.


Kari Stoever, M.B.A. - Director, Global Network for Neglected Tropical Disease Control

Kari Stoever leads Sabin's strategic planning and Neglected Tropical Diseases control initiatives.  She joined Sabin in 2004 to lead the Human Hookworm Vaccine Initiative and one year ago transitioned to establish the Global Network.  She played a key role in development of the USAID NTD proposal awarded in 2006.  She led the development of the Global Network, its website, advocacy materials, as well as development of strategic plans and public relations materials. She participated in the Clinton Global Initiative and has made key contacts with policy makers and opinion leaders in the United States.  She holds a B.Sc. from George Washington University, a degree in nursing, and an Executive Masters in Business Leadership from the McDonough School of Business, Georgetown University.